Skip to main content
. Author manuscript; available in PMC: 2018 Feb 12.
Published in final edited form as: Biometals. 2015 Feb 8;28(3):541–551. doi: 10.1007/s10534-015-9830-3

Scheme 3.

Scheme 3

Synthesis of reduction triggered desferrioxamine-ciprofloxacin conjugate 13. Reagents and conditions: (i) SOCl2, MeOH, reflux, 77%; (ii) NaN3, MeOH-H2O, rt, 91%; (iii) 1. PPh3, CH2Cl2, rt; 2. AcOH, THF-H2O, reflux, 66%; (iv) 1. COCl2, toluene, rt; (v) desferrioxamine mesylate, Et3N, DMF, 0°C-rt, 74% for 2 steps; (vi) LiOH, MeOH-H2O, rt, 90%; (vii) ciprofloxacin, EDC, HOBt, Et3N, DMAP, DMF, 0°C-rt, 60%